May Sulfab

*** ******** *** **** **** San Francisco, CA 94134 T: 510-***-**** Email: acs2rh@r.postjobfree.com

OBJECTIVE

A seasoned Legal Professional seeking a position where my past experience and education will be of mutual benefit to all concerned.

CORE COMPETENCIES

Over ten years experience in biotechnology and pharmaceutical industries

Certified patent prosecution practitioner

Experience in drafting and negotiating IP licenses

Skilled in applying basic patent law principles and procedures

Self-motivated, possess problem-solving skills, energetic, and have good communication skills

Management Training 2008, Foster City, CA. Two day long sessions on effective management skills

Power speaking, 2008, Foster City, CA. Day long professional speaking training

PROFESSIONAL EXPERIENCE

Rahman LLC Columbia, MD Feb 2015-Present

Patent Agent

Patent drafting and prosecution in the areas of biotechnology, pharmaceuticals, and medical devices

Prepare and draft patent validity opinions and infringement analysis

Implement and develop protection strategies for IP

Assist in identifying patentable products and features of products

Prepare appeal briefs and amendments in response to USPTO actions

Conduct preliminary patent searches as needed

Fernandez & Associate, LLP Atherton, CA 2013- 2014

Provided startup companies strategic business assistance and hands-on consultation regarding technology and intellectual property law

Researched patent laws and conducted patentability, infringement and validity analyses

Assisted in preparation of patent applications and manage communication with USPTO

Conducted patent prosecution filing appeal briefs and amendments

Adhered to proprietorship practices and policies

Obtained, tracked, and managed patents of each client

Gilead Science Foster City, CA 2008-Present

Senior Research Associate

Working cooperatively with legal and research groups to assess and implement product development and possible prior art roadblocks

Prepare and review contracts including MTA, NDA, licensing agreements, and collaborative research agreements

Plan and execute decisional experiments that support the initiation and/or advancement of drug candidates molecular biology principles for liver fibrosis

Conduct various research methods to characterize mechanism of action of lead compounds

Identify new technologies that may increase throughout or enhance understanding of disease mechanisms

Work cross-functionally within the organization to achieve goals

Present research findings and recommendations to senior staff

Present data and reports in departmental research meetings

Intermune Brisbane, CA 2006-2008

Associate Scientist

Conducted research to determine potencies and mechanism of action of drug candidates

Designed and optimized in vitro studies for identification of induced proteins in pulmonary fibrosis

Optimized/executed assays to support preclinical platforms.

Developed new methodologies and laboratory protocols in conducting general research work

Acquired extensive hands-on experience with a range of techniques including cloning,

Completed quantitative and qualitative analysis of EMT and myofibroblast differentiation in vitro

Optimized/developed cell based assays for use in compound analogs screens

Presented data and reports in departmental research meetings.

Laboratory of Thomas Landerholm, PhD Sacramento, CA 2003-2005

Research project: Investigated factors that induce differentiation of progenitor cells of the proepicardium (PE) into coronary smooth muscle cells (cSMCs) during heart development.

Additional Experience

Research Associate II, Avigen, Alameda, CA 2002

Developed and optimized AAV vector production for gene therapy

Quantitative analysis of vector RNA and protein

Analyzed results, presented data, and interacted with various groups and projects

Revised/rewrote protocols

Trained employees on various assays

Production Specialist, MedImmune, Mountain View, CA 2000-2002

Optimized production of Master Virus Seed for flu vaccine Flumist

Investigated/optimized factors affecting allantoic fluid harvest volumes and viral potency

Revised/rewrote protocols

Trained new employees and contractors

EDUCATION & CERTIFICATION _

San Francisco School of Law San Francisco, CA June 2013

Juris Doctor

Sacramento State University Sacramento, CA January 2006

Master of Science, Molecular and Cellular Biology

Thesis title: “The Effect of TGF-β on Coronary Smooth Muscle Differentiation from Proepicardial Cells”

Marymount University Arlington, VA December 1998

Bachelor of Science

Biology with an emphasis in Molecular and Cellular Biology

United States Patent and Trademark Office

Selected Publications &Presentations

Zhang, Y., Sulfab, M., & Fernandez, D. Intellectual Property Protection Strategies for Nanotechnology. Nanotechnology Reviews (2013)

Hebner CM, Han B, Brendza KM, Nash M, Sulfab M, et al. The HCV Non-Nucleoside Inhibitor Tegobuvir Utilizes a Novel Mechanism of Action to Inhibit NS5B Polymerase Function. PLoS One 7(6):e39163 (2012)

Brendza KM, Lichti C, Vivian R, Hebner CM, Petra G, Sulfab M, Tayler J, et al. Mass Spectrometry as a Tool to Uncover a Novel Mechanism of Action for the HCV NS5B Polymerase Non-nucleoside Inhibitor Tegobuvir. J Am Soc Mass Spectrom (2012)

Sulfab M, Blat LM, Ozes O. Pirfenidone and Induced Epithelial to Mesenchymal Transition Interferon-Gamma 1b Inhibit TGFβ in Alveolar Epithelial Cells and Differentiation of Human Lung Fibroblasts. Am J Respir Crit Care Med; 175: A729 (2007)

Sulfab M, Blat LM, Ozes O. The Effects of Pirfenidone and Interferon Inducible T- Cell Alpha Chemoattractant on Transforming Growth Factor-β1-Mediated Synthesis of Extracellular Matrix Proteins in Endothelial Cells. Am J Respir Crit Care Med ; 175: A730 (2007)

Sulfab M, Singh B, Landerholm TE. The Control of Coronary Artery Smooth Muscle Differentiation by Exogenous Growth Factors In Vitro and Elimination of Transforming Growth Factor-β Receptor Type II by Dominant-Negative Inhibition. Mol Biol Cell 22:L367 (2005)

Contact this candidate